Pentavalent Vaccine in the Uniject™ Injection System: A Time and Motion Study

A fully liquid pentavalent vaccine presented in the Uniject™ injection system is currently in development and targeted for use in developing countries. To understand the perceived benefits and challenges related to pentavalent vaccine in Uniject in comparison to alternative presentations of pentavalent vaccine, a time and motion study was planned in 2010 and carried out in 2011.

Publication date: June 2014

Pentavalent Vaccine in the Uniject™ Injection System

729.1 KB PDF

Hard copies are not available.

View Resource